ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• When To Use Wearables In A Clinical Trial And How to Get Started

  Wearables work best when they close real measurement gaps — from irregular symptoms to mobility and sleep. In a unified data environment, they deliver richer insights without added complexity.

• Maximizing Site Performance: The Hidden Benefits Of Unified eConsent And EDC

  Disconnected systems for eConsent and EDC create inefficiencies that burden clinical trial teams, but modern integrated platform solutions are streamlining operations.

• What Are Decentralized Clinical Trials (DCTs)?

  Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.

• Strategies To Minimize Participant And Healthcare Provider Burden

  Patient-reported outcomes (PROs) are vital for clinical trials but can burden participants and providers. Discover strategies and practical solutions to ease these burdens and improve data quality.

• eCOA 101: What Is Electronic Clinical Outcome Assessment?

  Electronic Clinical Outcome Assessment (eCOA) has transformed data collection in clinical trials by prioritizing patient engagement and improving data accuracy.

• Hidden Costs Of Data Cleaning: Build Quality At The Source

  Hidden costs from downstream data cleaning slow trials and raise risk. Explore why building quality at the source accelerates timelines, reduces errors, and gives sponsors a competitive edge.

• A Guide To RTSM For Clinical Trials

  Looking ahead, the evolution of RTSM in clinical trials points towards cloud-based solutions, heightened emphasis on patient safety, and greater collaboration among stakeholders. Learn how you can prepare.

• Building A Gold Standard Trial Experience In Japan

  Hear how Medable worked with a Japanese sponsor to elevate their trial experience, achieve >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards adopted across all the customer’s vendors.

• The FDA Just Rewrote The Rules For Clinical Trials. Here's What It Means For RTSM.

  Learn how evolving trial designs are changing RTSM requirements and driving demand for greater flexibility, traceability, and execution quality.

• Partnership Driving Superior Enrollment And Speed In Phase III Trial

  Examine the partnership between CRIO and Sitero, including how it underscores the significant impact of technology in optimizing trial performance and accelerating treatment development.